We are live on ! Find out more
SYNB

Putnam BioRevolution ETF

Delisted

SYNB was delisted on the 13th of November, 2025.

0 hedge funds and large institutions have $0 invested in Putnam BioRevolution ETF in 2025 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

83.41% less ownership

Funds ownership: 83.41%0% (-83%)

100% less funds holding

Funds holding: 50 (-5)

100% less capital invested

Capital invested by funds: $4.36M → $0 (-$4.36M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 5

Holders
Holders Change
-5
Holders Change %
-100%
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
5
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Franklin Resources
1
Franklin Resources
California
-$3.59M -120,000 Closed
Royal Bank of Canada
2
Royal Bank of Canada
Ontario, Canada
-$389K -13,024 Closed
Susquehanna International Group
3
Susquehanna International Group
Pennsylvania
-$357K -11,931 Closed
UBS Group
4
UBS Group
Switzerland
-$30.3K -1,013 Closed
Osaic Holdings
5
Osaic Holdings
Arizona
-$60 -2 Closed

SYNB Hedge Fund Activity: Q4 2025 in Review

0 of the 8,225 institutional investors tracked by Wall St. Rank reported a position in Putnam BioRevolution ETF (SYNB) for Q4 2025, worth a combined $0 — down 100% from $4.36M a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of SYNB and 0 opened new positions — a net loss of 5 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Franklin Resources, exiting entirely with an estimated $3.59M sold.

  • 0 institutional investors held Putnam BioRevolution ETF (SYNB) as of Q4 2025, down from 5 in Q3 2025.
  • Funds reported $0 of Putnam BioRevolution ETF stock for Q4 2025, down 100% quarter-over-quarter.
  • 0 funds opened new Putnam BioRevolution ETF positions in Q4 2025 and 5 closed out, a net change of -5 holders.
  • The largest Putnam BioRevolution ETF seller in Q4 2025 was Franklin Resources, an estimated $3.59M sold.

Based on aggregated 13F filings for Q4 2025.